Atlas Trials

Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Clinical trial NCT00499265 · COMPLETED

Trial details

NCT number
NCT00499265
Sponsor
Heidelberg Pharma AG
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2007-04-01
Primary completion
2010-05-01
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.